The Creation of New ICD-10 Codes for Post-Covid Vaccine Syndrome
The Creation of New ICD-10 Codes for Post-Covid Vaccine Syndrome
by Christopher Dreisbach at Brownstone Institute
“If you define the problem correctly, you almost have the solution.”
― Steve Jobs
Definitions matter. In almost any context, problems left undefined inevitably remain problems left unsolved.
For this reason, healthcare professionals worldwide rely upon the International Classification of Diseases, Tenth Revision (ICD-10), a standardized system used to categorize and code diseases, symptoms, and health conditions. In the United States, ICD-10 codes serve as the foundation for medical records, insurance billing, epidemiological research, and public health policy. Without specific ICD-10 codes, severe conditions may remain invisible in the healthcare data ecosystem—making it harder to track, study, or provide adequate care.
This is precisely the challenge facing thousands of Americans suffering from persistent severe adverse events after receiving a Covid vaccine—a condition recently defined as Post-Covid Vaccine Syndrome (PCVS). As one of those individuals, I know all too well how debilitating and life-altering this condition can be. Our symptoms include exercise intolerance, excessive fatigue, brain fog, insomnia, and dizziness. They develop shortly after vaccination, within a day or two, can become more severe in the days that follow, and persist over time.
At present, there are no dedicated ICD-10 codes for PCVS. This absence has significant consequences for patients, clinicians, researchers, and policymakers alike.
Visibility in the Healthcare System
One of the primary functions of ICD-10 codes is to make a condition visible within the healthcare system. Without specific codes, PCVS is at best recorded under vague categories like “unspecified adverse effect of vaccine” or “other specified postvaccination complication.” Leery of contradicting the safe and effective narrative, many providers simply utilize codes for general symptoms such as “fatigue” or “paresthesia.” As a result, PCVS is effectively lost in a sea of unrelated data.
Dedicated codes would allow providers to document PCVS in a standardized way, ensuring it is recognized in patient records, insurance claims, and national health databases. This visibility is crucial for legitimizing PCVS in the eyes of both a conflicted medical community and a polarized public.
Facilitating Research and Data Collection
Medical research thrives on accurate, reliable data. Without discrete ICD-10 codes, it is extremely difficult to track how many of us are affected by PCVS, what our symptoms are, how long they last, and what treatments are effective.
Currently, researchers who want to study PCVS must sift through miscellaneous adverse event codes, searching for possible cases—a process that is slow, imprecise, and prone to undercounting. Specific codes would enable more precise epidemiological studies, making it easier to identify risk factors, compare outcomes, and develop evidence-based treatment guidelines.
Improving Public Health Response and Policy
Public health agencies use ICD-10 coding data to monitor trends, allocate resources, and shape policy decisions. The lack of codes for PCVS means that policymakers are operating without a complete picture of vaccine safety profiles and long-term outcomes.
By establishing dedicated codes, health officials could more accurately assess the frequency and severity of PCVS, helping them balance the benefits and risks of vaccination programs and design better safety monitoring systems in the future. This transparency would strengthen public confidence in vaccination campaigns by demonstrating that potential adverse events are being taken seriously and tracked systematically.
Reducing Stigma and Improving Clinical Recognition
Those of us suffering from PCVS often face intense skepticism, with our symptoms crudely dismissed as unrelated or psychosomatic. The absence of recognized diagnostic codes can inadvertently reinforce this stigma, making it harder for those suffering with PCVS to be taken seriously.
Specific ICD-10 codes would send a clear signal to clinicians that PCVS is a legitimate medical condition worthy of investigation, empathy, and appropriate care.
Ethical and Societal Responsibility
Healthcare systems have an ethical duty to acknowledge and address all medical conditions – especially those that may be rare or controversial. Creating specific ICD-10 codes for PCVS would demonstrate a commitment to transparency, patient welfare, and scientific inquiry.
This step would not undermine legitimate vaccination efforts; rather, it would enhance them by showing the public that adverse events are being tracked rigorously and addressed proactively. Public health trust depends not only on promoting the benefits of a medical intervention but also on an honest acknowledgment of its risks, however small.
Aligning with the Approach to Long Covid
The World Health Organization and the US Centers for Disease Control and Prevention (CDC) have already recognized the need for specific ICD-10 codes for post-acute sequelae of Covid, commonly known as Long Covid. These codes have helped researchers and clinicians better identify, study, and manage that condition.
The same logic applies to PCVS. Both prolonged conditions involve complex overlapping symptoms following an acute event (infection or vaccination) and require long-term monitoring.
For that reason, React19, a science-based 501(c) non-profit organization dedicated solely to supporting those suffering from long-term Covid vaccine adverse events, has submitted a formal proposal to the CDC’s National Center for Health Statistics to create ICD-10 codes for PCVS mirroring those for Long Covid.
PCVS Patients Deserve Action, not Argument
“We can ignore reality, but we cannot ignore the consequences of ignoring reality.”
― Ayn Rand
While opinions differ greatly to what extent – by all credible accounts the Covid vaccines simply did not perform as public health officials assured the American public they would. As to efficacy, they failed to stop transmission and infection. As to safety, in addition to the emergence of PCVS, the CDC has conceded that myocarditis and pericarditis are “linked to certain types of COVID-19 vaccinations.” And of course, the Johnson & Johnson vaccine was pulled entirely from the market after multiple cases of fatal blood clotting after vaccinations.
Yale Medical School professor of cardiology Dr. Harlan Krumholtz well summarized, “It’s clear that some individuals are experiencing significant challenges after vaccination. Our responsibility as scientists and clinicians is to listen to their experiences, rigorously investigate the underlying causes, and seek ways to help.” Creating distinct ICD-10 codes for PCVS mirroring those currently utilized to identify Long Covid would be the logical first step to provide this much needed support.
Failure to create specific ICD-10 codes for PCVS would be to ignore the agonizing reality of the syndrome, leaving the sick and suffering to face the grim consequences of inaction – left adrift in a medical system unwilling to acknowledge our existence and desperate need for treatment. We must expect more of our public health agencies – those debilitated by PCVS deserve no less.
The Creation of New ICD-10 Codes for Post-Covid Vaccine Syndrome
by Christopher Dreisbach at Brownstone Institute – Daily Economics, Policy, Public Health, Society